Research at
African Institute of Biomedical Science & Technology

• Molecular Sciences
• Pharmacology
• Medicinal Chemistry
• DMPK/PD-Toxicology
• Clinical Sciences
• Pharmaceutics and Drug Manufacturing
• Bioanalytical Chemistry

About Us

The African Institute of Biomedical Science & Technology, AiBST, was established in 2002 with the aim to strengthen African’s scientific & technical capacity to contribute to healthcare solutions for its people.

It is a private not-for-profit research and education institute which is registered with the Ministry of Higher & Tertiary Education and works closely with the Ministry of Health & Child Welfare and the Ministry of Science Technology Development

Biomedical
Research & Development

AiBST has established state-of-the-art laboratories in Zimbabwe. Research at AiBST aims at drug discovery, development and optimal clinical use of medicines.

It is the WHO-TDR and the African Network for Drugs and Diagnostics Innovation (ANDi) CoE in DMPK and Toxicology. It is also a leading centre for pharmacogenomic studies and is the leader of the African Pharmaco- genomics Consortium

Postgraduate Training
and Continuing Professional Biomedical

To increase the skilled human resource base for cutting edge biomedical science & technology, AiBST has a postgraduate (MSc & PhD) training program which attracts many young scientists from across Africa.

It also conducts advanced biomedical courses for both postgraduate students and professionals to encourage adoption of best and current technologies & practices in institutions of life sciences.

Biomedical
Entrepreneurship

In a bid to promote lab-bench to patient-bedside or product on the market biomedical R&D, AiBST has a biomedical entrepreneurship unit.In this unit biomedical businesses are incubated with the idea to finally wean them off as private independent companies.

Current business incubations include Molecular Diagnostics, Drug Discovery ADMET/PK Services, & Distribution of Biomedical Reagents for Drug Discovery Research.